Woman and Man
- | Country : -
- | organs : -
- | Specialty : -
Extract
To determine the effectiveness of AMG 162 in reducing urinary N-telopeptide (uNTx) below 50 nM BCE / mM creatinine in advanced cancer subjects with bone metastases (including multiple myeloma subjects with bone disease) with uNTx levels above 50 nM BCE / mM creatinine during intravenous bisphosphonate treatment.
Inclusion criteria
- Bone metastases of solid tumors (except lung) or multiple myeloma bone disease